• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在甲状腺乳头状癌中的表达谱及临床意义

Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.

作者信息

Peng You, Li Chen, Luo Ding-Cun, Ding Jin-Wang, Zhang Wo, Pan Gang

机构信息

Department of Oncological Surgery, Hangzhou First People's Hospital, Hangzhou 310006, China.

Department of General Surgery, Wuxi Second People's Hospital, Wuxi 214000, China.

出版信息

Molecules. 2014 Aug 5;19(8):11586-99. doi: 10.3390/molecules190811586.

DOI:10.3390/molecules190811586
PMID:25100252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6271659/
Abstract

This study screened microRNAs (miRNAs) that are abnormally expressed in papillary thyroid carcinoma (PTC) tissues to identify PTC and nodular goiter and the degree of PTC malignancy. A total of 51 thyroid tumor tissue specimens paired with adjacent normal thyroid tissues were obtained from the Department of Surgical Oncology of Hangzhou First People's Hospital from June-December 2011. miRNA expression profiles were examined by microarrays and validated by quantitative real-time PCR (qRT-PCR). Expression levels of the miRNAs were analyzed to assess if they were associated with selected clinicopathological features. Eleven miRNAs were significantly differentially expressed between nodular goiter and PTC and between highly invasive and low invasive PTC. miR-199b-5p and miR-30a-3p were significantly differentially expressed among the three groups. miR-30a-3p, miR-122-5p, miR-136-5p, miR-146b-5p and miR-199b-5p were selected for further study by qRT-PCR and miR-146b-5p, miR-199b-5p and miR-30a-3p were different between the PTC and nodular goiter groups. miR-199b-5p was over-expressed in PTC patients with extrathyroidal invasion and cervical lymph node metastasis. In conclusion miR-146b-5p, miR-30a-3p, and miR-199b-5p may serve as biomarkers for the diagnosis of PTC and miR-199b-5p is associated with PTC invasiveness.

摘要

本研究筛选了在甲状腺乳头状癌(PTC)组织中异常表达的微小RNA(miRNA),以鉴别PTC与结节性甲状腺肿以及PTC的恶性程度。2011年6月至12月期间,从杭州市第一人民医院外科肿瘤科获取了51例甲状腺肿瘤组织标本及其配对的相邻正常甲状腺组织。通过微阵列检测miRNA表达谱,并通过定量实时聚合酶链反应(qRT-PCR)进行验证。分析miRNA的表达水平,以评估它们是否与选定的临床病理特征相关。在结节性甲状腺肿与PTC之间以及高侵袭性和低侵袭性PTC之间,有11种miRNA存在显著差异表达。miR-199b-5p和miR-30a-3p在三组之间存在显著差异表达。通过qRT-PCR选择miR-30a-3p、miR-122-5p、miR-136-5p、miR-146b-5p和miR-199b-5p进行进一步研究,且miR-146b-5p、miR-199b-5p和miR-30a-3p在PTC组和结节性甲状腺肿组之间存在差异。miR-199b-5p在伴有甲状腺外侵犯和颈部淋巴结转移的PTC患者中过度表达。总之,miR-146b-5p、miR-30a-3p和miR-199b-5p可能作为PTC诊断的生物标志物,且miR-199b-5p与PTC的侵袭性相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/6271659/7755c17df554/molecules-19-11586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/6271659/7755c17df554/molecules-19-11586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc85/6271659/7755c17df554/molecules-19-11586-g001.jpg

相似文献

1
Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.微小RNA在甲状腺乳头状癌中的表达谱及临床意义
Molecules. 2014 Aug 5;19(8):11586-99. doi: 10.3390/molecules190811586.
2
New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.甲状腺乳头状癌原发肿瘤和淋巴结转移灶的微小RNA转录组的新全球分析。
BMC Genomics. 2015 Oct 21;16:828. doi: 10.1186/s12864-015-2082-3.
3
Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.鉴别微小 RNA 用于管理甲状腺乳头状癌和具有甲状腺滤泡肿瘤乳头状核特征的非侵袭性肿瘤。
Thyroid. 2018 Mar;28(3):319-327. doi: 10.1089/thy.2017.0127. Epub 2018 Mar 2.
4
Aberrant expression of five miRNAs in papillary thyroid carcinomas.五种微小 RNA 在甲状腺乳头状癌中的异常表达。
J Clin Lab Anal. 2021 Sep;35(9):e23907. doi: 10.1002/jcla.23907. Epub 2021 Jul 16.
5
Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.微小RNA-30a-5p在甲状腺乳头状癌中的表达水平:血清与细针穿刺活检样本的比较
Genet Test Mol Biomarkers. 2015 Aug;19(8):418-23. doi: 10.1089/gtmb.2015.0062. Epub 2015 Jun 5.
6
[Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].[微小RNA-221和白细胞介素-17在甲状腺乳头状癌中的表达及其与临床病理特征的相关性]
Zhonghua Bing Li Xue Za Zhi. 2017 Mar 8;46(3):160-165. doi: 10.3760/cma.j.issn.0529-5807.2017.03.004.
7
MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting in Human Papillary Thyroid Cancer.miR-146b-3p 通过直接靶向在人甲状腺乳头状癌中促进细胞转移。
Thyroid. 2018 Dec;28(12):1627-1641. doi: 10.1089/thy.2017.0626. Epub 2018 Oct 27.
8
Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.甲状腺乳头状癌中miR-146a和miR-146b表达与临床特征的相关性
Cancer Biomark. 2015;15(1):33-40. doi: 10.3233/CBM-140431.
9
miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.miR-146a 和 miR-146b 在甲状腺乳头状癌的诊断和预后中的作用。
Oncol Rep. 2017 Nov;38(5):2735-2740. doi: 10.3892/or.2017.5994. Epub 2017 Sep 25.
10
Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.综合 microRNA 表达谱分析鉴定滤泡型甲状腺癌的新型标志物。
Thyroid. 2013 Nov;23(11):1383-9. doi: 10.1089/thy.2012.0632. Epub 2013 Sep 19.

引用本文的文献

1
Diagnosis and Evaluation of Aggressiveness Using Circulating Plasma miRNAs in Papillary Thyroid Microcarcinoma.利用循环血浆微小RNA诊断和评估甲状腺微小乳头状癌的侵袭性
Cancers (Basel). 2025 Jun 21;17(13):2079. doi: 10.3390/cancers17132079.
2
Research and progress of microRNA-136 in metastatic tumors.微小RNA-136在转移性肿瘤中的研究进展
Front Oncol. 2025 Mar 4;15:1555270. doi: 10.3389/fonc.2025.1555270. eCollection 2025.
3
MicroRNA-452: a double-edged sword in multiple human cancers.微小 RNA-452:多种人类癌症中的双刃剑。

本文引用的文献

1
New insights into the diagnosis of nodular goiter.结节性甲状腺肿诊断的新见解。
Thyroid Res. 2014 Jun 17;7:6. doi: 10.1186/1756-6614-7-6. eCollection 2014.
2
Low risk papillary thyroid cancer.低危型甲状腺乳头状癌。
BMJ. 2014 Jun 16;348:g3045. doi: 10.1136/bmj.g3045.
3
The role of microRNA in head and neck cancer: current knowledge and perspectives.微小RNA在头颈癌中的作用:当前认知与展望
Clin Transl Oncol. 2023 May;25(5):1189-1206. doi: 10.1007/s12094-022-03041-0. Epub 2023 Jan 9.
4
Diagnostic Significance of FNAB miRNA Expression in Papillary Thyroid Carcinoma.细针穿刺抽吸活检(FNAB)中微小RNA(miRNA)表达在甲状腺乳头状癌中的诊断意义
Diagnostics (Basel). 2022 Jun 3;12(6):1384. doi: 10.3390/diagnostics12061384.
5
MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.甲状腺乳头状癌中的微小RNA:诊断与治疗的新进展
Front Oncol. 2022 Feb 3;11:755097. doi: 10.3389/fonc.2021.755097. eCollection 2021.
6
CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.环状RNA NRIP1通过吸附mir-195-5p并调节P38丝裂原活化蛋白激酶和JAK/STAT信号通路促进甲状腺乳头状癌进展。
Diagn Pathol. 2021 Oct 25;16(1):93. doi: 10.1186/s13000-021-01153-9.
7
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer.甲状腺乳头癌囊泡外体血清 microRNA 分析。
Endocrine. 2022 Jan;75(1):185-193. doi: 10.1007/s12020-021-02847-2. Epub 2021 Aug 10.
8
Translational Utility of Liquid Biopsies in Thyroid Cancer Management.液体活检在甲状腺癌管理中的转化应用价值
Cancers (Basel). 2021 Jul 9;13(14):3443. doi: 10.3390/cancers13143443.
9
Aberrant expression of five miRNAs in papillary thyroid carcinomas.五种微小 RNA 在甲状腺乳头状癌中的异常表达。
J Clin Lab Anal. 2021 Sep;35(9):e23907. doi: 10.1002/jcla.23907. Epub 2021 Jul 16.
10
Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors.14q32编码的微小RNA在内分泌肿瘤中的重要作用。
Genes (Basel). 2021 May 8;12(5):698. doi: 10.3390/genes12050698.
Molecules. 2014 May 5;19(5):5704-16. doi: 10.3390/molecules19055704.
4
Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.血清中微小RNA-196a和微小RNA-196b的联合升高预示骨肉瘤患者预后不良。
Int J Mol Sci. 2014 Apr 17;15(4):6544-55. doi: 10.3390/ijms15046544.
5
Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers.微小RNA146b、221、222及p27Kip1蛋白mRNA表达水平与甲状腺乳头状癌临床病理参数的相关性
Exp Clin Endocrinol Diabetes. 2014 Mar;122(3):137-43. doi: 10.1055/s-0034-1367025. Epub 2014 Mar 18.
6
Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.差异性miRNA表达决定了滤泡状甲状腺癌的迁移能力及凋亡减少。
Mol Cell Endocrinol. 2014 May 5;388(1-2):1-9. doi: 10.1016/j.mce.2014.02.011. Epub 2014 Mar 12.
7
Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.微小RNA检测在胃肠道神经内分泌肿瘤中的临床应用
Molecules. 2014 Feb 21;19(2):2458-68. doi: 10.3390/molecules19022458.
8
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.低分化甲状腺癌的 microRNA 谱:新的诊断和预后见解。
J Mol Endocrinol. 2014 Mar 6;52(2):181-9. doi: 10.1530/JME-13-0266. Print 2014 Apr.
9
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.miR-222 和 miR-146b 是复发性甲状腺乳头状癌的组织和循环生物标志物。
Cancer. 2013 Dec 15;119(24):4358-65. doi: 10.1002/cncr.28254. Epub 2013 Oct 28.
10
Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.侵袭性甲状腺乳头状癌中 microRNA 和 mRNA 表达谱的综合分析。
Mol Med Rep. 2013 Nov;8(5):1353-8. doi: 10.3892/mmr.2013.1699. Epub 2013 Sep 24.